It has previously been demonstrated that xenograft rejection in rodents is
dependent on CD4(+) T cells. However, because of the lack of an appropriate
in vivo model, Little is known about the cellular basis of human T cell-me
diated rejection of xenografts, In this study, we have evaluated the abilit
y of human T cells to mediate rejection of porcine skin grafts in a novel i
n vivo experimental system using immunodeficient mice as recipients, Recomb
inase-activating gene-1-deficient mice (R-) lacking mature B and T cells we
re grafted with porcine skin and received human lymphocytes stimulated in v
itro crith irradiated porcine PBMC. Skin grafts on mice given either unsepa
rated, activated human lymphocytes . or NK cell-depicted lymphocyte populat
ions were rejected within 18 days after adoptive cell transfer, In contrast
, skin grafts on mice given T cell-depleted human lymphocytes or saline sho
wed no gross or histologic evidence of rejection up to 100 days after adopt
ive transfer. Purified CD4(+) T cells were also able to mediate rejection o
f porcine skin grafts. These data suggest that human CD4(+) T cells are suf
ficient to induce rejection of porcine xenografts. Thus, strategies directe
d toward CD4(+) T cells ma effectively prevent cellular rejection of porcin
e xenografts in humans.